FDA to Issue Final Guidance on Dear HCP Letters
Tomorrow, FDA plans to issue final guidance on Dear Health Care Professional Letters. The guidance addresses when it is appropriate to use Dear Health Care Professional Letters, what type of information should be included, how to organize the information, and formatting techniques to improve accessibility. This guidance finalizes the agency’s draft guidance on this subject issued in November 2010. You can access the advance notice in the Federal Register and the full text of the guidance below.
On 26 September 2016, a new EU-US collaboration between the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) was announced. This new collaboration is ...06 October 2016
On 1 September 2016, the European Medicines Agency ("EMA") opened for public consultation a Draft revision to its Guideline on the assessment of clinical safety and efficacy in the...08 September 2016